Reckitt Benckiser: A FTSE 100 Dividend-Raising Star

LONDON -- In an outcome that's tough on investors, the FTSE 100 (INDEX: ^FTSE ) has failed to deliver a rising dividend payout over the last few years.

Just look at the iShares FTSE 100 ETF, for example. This is an exchange-traded fund that tracks the benchmark index, and we can see that the aggregate payment from Britain's top 100 companies has yet to regain its pre-recession peak:

Year	2007	2008	2009	2010	2011
Dividend per share	19.1p	20.2p	17.1p	16.2p	18.1p

That's disappointing. But some companies within London's premier index have performed well on dividends, despite these austere times, and this series aims to seek them out. One such name is Reckitt Benckiser (LSE: RB.L ) .

The big question is can Reckitt's dividend continue to outperform its index? Let's put the firm under scrutiny and test its financial mettle.

Reckitt Benckiser is a household cleaning products manufacturer with worldwide operations. With the shares at 3,592 pence, the market cap is around 26 billion pounds. This table summarizes the company's recent financial performance:

Year	2007	2008	2009	2010	2011
Revenue (millions of pounds)	5,269	6,563	7,753	8,453	9,485
Net cash from operations (millions of pounds)	975	1,333	1,948	1,544	1,740
Earnings per share	127.9 pence	154.7 pence	194.7 pence	213.8 pence	237.1 pence
Dividend per share	55 pence	80 pence	100 pence	115 pence	125 pence

So the dividend has increased by 127% during the last five years -- equivalent to a 22.8% compound annual growth rate.

Reckitt and Benckiser merged in 1999 after developing as individual businesses throughout the 19th century. Today, the company is the world's largest household cleaning products manufacturer with more than half its revenues generated from its fabric care and surface care divisions.

Reckitt's strong consumer brands drive the success of its operation, such as Finish, Dettol, and Cillit Bang. As well as developing new names in house, the firm keeps watch for well-known brands that it can acquire to help fuel its expansion. In 2005, it added the Nurofen, Strepsil, and Clearasil brands to its portfolio with the 1.9 billion pound acquisition of Boots Healthcare International.

Right now, the firm derives around 43% of revenue from Europe, 25% from North America and Australia, 24% from developing markets, and 8% from its pharmaceutical division. Developing markets have powered recent sales growth. That's encouraging, as Reckitt has a fine history of converting revenue growth to cash flow growth-ideal for supporting a progressive dividend policy.

Reckitt Benckiser's dividend growth score

I analyze four different features of a company to judge whether its dividend can continue to rise:

1. Dividend cover: Earnings covered the recent dividend around 1.9 times. 3/5

2. Net cash/debt: The recent interim results showed net gearing around 34%. 4/5

3. Cash flow: Cash flow supports profits and both are trending up. 5/5

4. Outlook and recent trading: Both recent trading and the outlook are good. 4/5

Overall, I score Reckitt Benckiser 16 out of 20, which encourages me to believe the firm's dividend can continue to outpace dividends from the FTSE 100.

Foolish summary
Although dividend cover is lower than I would like to see, Reckitt's cash flow credentials, manageable borrowings figure, and positive trading outlook are all reassuring.

Right now, Reckitt's forecast full-year dividend is 132.24 pence per share for 2013, which supports a possible income of 3.7%. That looks attractive to me.

Reckitt Benckiser is one of several dividend outperformers on the London stock exchange. There's one man who's as keen as I am to find, and invest, in them. I suggest you read all about his best investment ideas now in this free, time-limited report, while you have the chance: 8 Income Plays Held By Britain's Super Investor. This free report analyses the 20 billion pound portfolio of legendary high-yield expert Neil Woodford. Click here now to discover his favorite dividend opportunities with good growth potential.

If you are an ambitious investor hoping to profit from this uncertain economy, as I am, I urge you to read "Ten Steps To Making A Million In The Market" today -- it could transform your wealth. Click here now to request your free, no-obligation copy. The Motley Fool is helping Britain invest. Better.

Further investment opportunities:

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Kevin does not own any shares mentioned in this article. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.